Cathie Wood Is Buying This Under-the-Radar AI Stock
Many famous names on Wall Street are rapidly scooping up shares of the most prominent artificial intelligence (AI) companies, including Nvidia and , among other tech giants. Though these market leaders are attracting most of the AI-centered attention, there are smaller players in the field, such as Recursion Pharmaceuticals (NASDAQ: RXRX).
This mid-cap biotech uses AI in an innovative way (more on that below). It has attracted the attention of a notable player on the street: Cathie Wood, CEO of Ark Invest. Let's see what makes this stock intriguing.
Ark Invest seeks out disruptive technologies that are shaping the future. One of their actively managed exchange-traded funds (ETFs), ARK Genomic Revolution, targets companies trying to improve the quality of life through scientific innovation.
Source Fool.com
Alphabet Inc. C Stock
The stock is an absolute favorite of our community with 26 Buy predictions and no Sell predictions.
With a target price of 165 € there is a positive potential of 20.21% for Alphabet Inc. C compared to the current price of 137.26 €.
